IRIS Accounts Production v25.1.0.734 OC309967 designated member 1.11.23 31.10.24 31.10.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhOC3099672023-10-31OC3099672024-10-31OC3099672023-11-012024-10-31OC3099672022-10-29OC3099672022-10-302023-10-31OC3099672023-10-31OC309967ns15:EnglandWales2023-11-012024-10-31OC309967ns14:PoundSterling2023-11-012024-10-31OC309967ns10:PartnerLLP12023-11-012024-10-31OC309967ns10:LimitedLiabilityPartnershipLLP2023-11-012024-10-31OC309967ns10:SmallEntities2023-11-012024-10-31OC309967ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-31OC309967ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-31OC309967ns10:LimitedLiabilityPartnershipsSORP2023-11-012024-10-31OC309967ns10:FullAccounts2023-11-012024-10-31OC30996712023-11-012024-10-31OC309967ns10:PartnerLLP22023-11-012024-10-31OC309967ns10:RegisteredOffice2023-11-012024-10-31OC309967ns5:CurrentFinancialInstruments2024-10-31OC309967ns5:CurrentFinancialInstruments2023-10-31OC309967ns5:NetGoodwill2023-11-012024-10-31OC309967ns5:NetGoodwill2023-10-31OC309967ns5:NetGoodwill2024-10-31OC309967ns5:NetGoodwill2023-10-31OC309967ns5:LandBuildings2023-10-31OC309967ns5:LeaseholdImprovements2023-10-31OC309967ns5:FurnitureFittings2023-10-31OC309967ns5:LandBuildings2023-11-012024-10-31OC309967ns5:LeaseholdImprovements2023-11-012024-10-31OC309967ns5:FurnitureFittings2023-11-012024-10-31OC309967ns5:LandBuildings2024-10-31OC309967ns5:LeaseholdImprovements2024-10-31OC309967ns5:FurnitureFittings2024-10-31OC309967ns5:LandBuildings2023-10-31OC309967ns5:LeaseholdImprovements2023-10-31OC309967ns5:FurnitureFittings2023-10-31OC309967ns5:MotorVehicles2023-10-31OC309967ns5:ComputerEquipment2023-10-31OC309967ns5:MotorVehicles2023-11-012024-10-31OC309967ns5:ComputerEquipment2023-11-012024-10-31OC309967ns5:MotorVehicles2024-10-31OC309967ns5:ComputerEquipment2024-10-31OC309967ns5:MotorVehicles2023-10-31OC309967ns5:ComputerEquipment2023-10-31OC309967ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-31OC309967ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-31
REGISTERED NUMBER: OC309967 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2024

for

Broadway Pharmacy (Staines) LLP

Broadway Pharmacy (Staines) LLP (Registered number: OC309967)






Contents of the Financial Statements
for the Year Ended 31 October 2024




Page

General Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Broadway Pharmacy (Staines) LLP

General Information
for the Year Ended 31 October 2024







DESIGNATED MEMBERS: Ms P Li
K Li
Ms J Li





REGISTERED OFFICE: 3 The Broadway
Kingston Road
Staines
Middlesex
TW18 1AT





REGISTERED NUMBER: OC309967 (England and Wales)






Broadway Pharmacy (Staines) LLP (Registered number: OC309967)

Balance Sheet
31 October 2024

31.10.24 31.10.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 25,738
Tangible assets 5 123,859 146,874
123,859 172,612

CURRENT ASSETS
Stocks 6 29,150 30,000
Debtors 7 276,476 290,536
Cash at bank 110,952 270,627
416,578 591,163
CREDITORS
Amounts falling due within one year 8 299,579 320,857
NET CURRENT ASSETS 116,999 270,306
TOTAL ASSETS LESS CURRENT LIABILITIES
and
NET ASSETS ATTRIBUTABLE TO
MEMBERS

240,858

442,918

Broadway Pharmacy (Staines) LLP (Registered number: OC309967)

Balance Sheet - continued
31 October 2024

31.10.24 31.10.23
Notes £    £    £    £   
LOANS AND OTHER DEBTS DUE
TO MEMBERS

9

228,302

430,362

MEMBERS' OTHER INTERESTS
Capital accounts 12,556 12,556
240,858 442,918

TOTAL MEMBERS' INTERESTS
Loans and other debts due to
members

9

228,302

430,362
Members' other interests 12,556 12,556
240,858 442,918

The LLP is entitled to exemption from audit under Section 477 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 for the year ended 31 October 2024.

The members acknowledge their responsibilities for:
(a)ensuring that the LLP keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the LLP as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 relating to financial statements, so far as applicable to the LLP.

The financial statements have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

In accordance with Section 444 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, the Income Statement has not been delivered.

The financial statements were approved by the members of the LLP and authorised for issue on 28 July 2025 and were signed by:





K Li - Designated member

Broadway Pharmacy (Staines) LLP (Registered number: OC309967)

Notes to the Financial Statements
for the Year Ended 31 October 2024

1. STATUTORY INFORMATION

Broadway Pharmacy (Staines) LLP is registered in England and Wales. The LLP's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial reporting Standard applicable in the UK and Republic of Ireland" and the companies Act 2006.
The financial statements have been prepared under historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of the business and, is
being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Freehold property : 2% straight line
Fixture and fittings : 10% straight line
Motor vehicles : 25% reducing balance
Computer equipment:25% reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits
The LLP operates a defined contribution pension scheme. Contributions payable to the LLP's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEE INFORMATION

The average number of employees during the year was 9 (2023 - 10 ) .

Broadway Pharmacy (Staines) LLP (Registered number: OC309967)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 November 2023
and 31 October 2024 514,722
AMORTISATION
At 1 November 2023 488,984
Amortisation for year 25,738
At 31 October 2024 514,722
NET BOOK VALUE
At 31 October 2024 -
At 31 October 2023 25,738

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
Freehold to and
property property fittings
£    £    £   
COST
At 1 November 2023 115,168 6,418 278,397
Additions - - 374
At 31 October 2024 115,168 6,418 278,771
DEPRECIATION
At 1 November 2023 115,168 513 172,449
Charge for year - 129 15,905
At 31 October 2024 115,168 642 188,354
NET BOOK VALUE
At 31 October 2024 - 5,776 90,417
At 31 October 2023 - 5,905 105,948

Broadway Pharmacy (Staines) LLP (Registered number: OC309967)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

5. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 November 2023 107,311 19,771 527,065
Additions - 1,749 2,123
At 31 October 2024 107,311 21,520 529,188
DEPRECIATION
At 1 November 2023 85,985 6,076 380,191
Charge for year 5,331 3,773 25,138
At 31 October 2024 91,316 9,849 405,329
NET BOOK VALUE
At 31 October 2024 15,995 11,671 123,859
At 31 October 2023 21,326 13,695 146,874

6. STOCKS
31.10.24 31.10.23
£    £   
Stocks 29,150 30,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Trade debtors 221,739 237,555
VAT 50,243 52,809
Prepayments and accrued income 4,494 172
276,476 290,536

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Bank loans and overdrafts - 476
Trade creditors 181,138 190,995
Social security and other taxes 2,480 4,010
Net Wages 14,226 9,511
Pension 451 709
Other creditors 101,284 115,156
299,579 320,857

Broadway Pharmacy (Staines) LLP (Registered number: OC309967)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

9. LOANS AND OTHER DEBTS DUE TO MEMBERS

Loans and other debts due to members are unsecured and would rank pari passu with other unsecured creditors in the event of a winding up.